Skip to main content
. 2019 Nov 15;10:5176. doi: 10.1038/s41467-019-13150-0

Fig. 4.

Fig. 4

At E7.75, Tlr2-labeled progenitors contribute to embryonic and fetal hematopoiesis. a Experimental design of the fate mapping of cells with an active Tlr2 locus. b The percentage of EYFP+ embryos among all Tlr2CreERT2Rosa26EYFP embryos in the same litter pulsed with one dose of 4-OHT from E6.75 to E10.5 was analyzed at E17.5 by FCM (mean ± SEM; n = 3–8 litters). c Percentage of Tlr2CreERT2EYFP+ cells in E17.5 fetal liver (FL, black dots) and E17.5 fetal thymus (FT, gray dots) in embryos described in (b); (mean ± SEM; n = 6–21 embryos). d The hematopoietic fate of Tlr2CreERT2EYFP+ cells pulsed with one dose of 4-OHT from E7.75 to E10.5 was determined in E17.5 FL and FT by FCM; (mean ± SEM; n = 4–8). e Labeling of hematopoietic populations (including granulocytes and monocytes) was determined in E13.5 FL of Tlr2CreERT2Rosa26tdTomato embryos pulsed with a single dose of 4-OHT at E7.75 (mean ± SEM; n = 8; arp = average recombination probability assessed in Ter119c-kitCD45 cells. f Gating strategy to identify the contribution of Tlr2CreERT2EYFP+ cells to indicated hematopoietic populations in E11.5 YS and FL. g Fate tracing of E11.5 Tlr2CreERT2EYFP+ cells pulsed with one dose of 4-OHT from E7.75 to E10.5 (mean ± SEM; n = 5–15) was analyzed by FCM according to (f). Source data are provided as a Source Data file